Brief: Athira Pharma Reports Q2 2022 Results

LeonaBio

15/08/2022 21:58

Aug 15 (Reuters) - Athira Pharma Inc  ATHA.O :
    * ATHIRA PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
RECENT CLINICAL AND CORPORATE UPDATES
    * Q2 LOSS PER SHARE $0.65

Source text for Eikon:  ID:nGNX5sdmCR 
Further company coverage:  ATHA.O 

 ((Reuters.Briefs@thomsonreuters.com;))